Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM2 | Q14416 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.30 |
| ▸ | PTGFR | P43088 | 1/20 | 0.30 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23267807 | 0.84 | ALDH1A1 (0.38) | GRM2ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL23268157 | 0.70 | KDM4E (0.37) | ALDH1A1KDM4E | |
| SCHEMBL23268389 | 0.69 | ALDH1A1 (0.39) | GRM2ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL13995076 | 0.67 | ALDH1A1 (0.37) | ALDH1A1GPR84KDM4EMEN1KMT2A | |
| SCHEMBL16352622 | 0.67 | CYP11B1 (0.41) | ALDH1A1GPR84KDM4EMEN1KMT2A | |
| SCHEMBL23267808 | 0.67 | PTGFR (0.35) | GRM2ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL23267809 | 0.67 | AURKA (0.39) | GRM2ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL23267752 | 0.67 | LMNA (0.32) | — | |
| SCHEMBL13995086 | 0.66 | CYP19A1 (0.35) | SOS1 | |
| SCHEMBL23268092 | 0.66 | ALDH1A1 (0.36) | GRM2ALDH1A1KDM4EMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210115077-A1 | Organometallic compound, organic light-emitting device including the same, and diagnosing composition including the organometallic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2021-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210115077-A1 | Organometallic compound, organic light-emitting device including the same, and diagnosing composition including the organometallic compound | L1CAM, MSL1, NOM1 | GRM2 747/4885ALDH1A1 118/4885GPR84 4553/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.